Elan gains Japanese patent on drugs technology

Pharmaceutical company Elan today announced that Japan's patent office has issued a patent certificate for Elan's proprietary NanoCrystal technology.

Elan said today that NanoCrystal technology may enhance the clinical performance of poorly water-soluble drugs by transforming them into nanometer-sized particles.

"This is a significant milestone in the development of new applications of our NanoCrystal

technology and may facilitate the expansion of our activities in Japan, one of the world's most

significant pharmaceutical markets," said Elan's executive vice president of global services and operations Paul Breen.